These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35031611)

  • 1. Structure and function of a family of tick-derived complement inhibitors targeting properdin.
    Braunger K; Ahn J; Jore MM; Johnson S; Tang TTL; Pedersen DV; Andersen GR; Lea SM
    Nat Commun; 2022 Jan; 13(1):317. PubMed ID: 35031611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.
    Corvillo F; Bravo García-Morato M; Nozal P; Garrido S; Tortajada A; Rodríguez de Córdoba S; López-Trascasa M
    Clin Exp Immunol; 2016 Apr; 184(1):118-25. PubMed ID: 26660535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin.
    Vuagnat BB; Mach J; Le Doussal JM
    Mol Immunol; 2000 Jun; 37(8):467-78. PubMed ID: 11090881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).
    Saggu G; Cortes C; Emch HN; Ramirez G; Worth RG; Ferreira VP
    J Immunol; 2013 Jun; 190(12):6457-67. PubMed ID: 23677468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properdin and complement activation: a fresh perspective.
    Hourcade DE
    Curr Drug Targets; 2008 Feb; 9(2):158-64. PubMed ID: 18288967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease.
    O'Flynn J; Kotimaa J; Faber-Krol R; Koekkoek K; Klar-Mohamad N; Koudijs A; Schwaeble WJ; Stover C; Daha MR; van Kooten C
    Kidney Int; 2018 Dec; 94(6):1141-1150. PubMed ID: 30322716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complement.
    Pedersen DV; Rösner T; Hansen AG; Andersen KR; Thiel S; Andersen GR; Valerius T; Laursen NS
    Mol Immunol; 2020 Aug; 124():200-210. PubMed ID: 32599335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural studies offer a framework for understanding the role of properdin in the alternative pathway and beyond.
    Pedersen DV; Lorentzen J; Andersen GR
    Immunol Rev; 2023 Jan; 313(1):46-59. PubMed ID: 36097870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary complement inhibitors from mosquitoes: Structure and mechanism of action.
    Strayer EC; Lu S; Ribeiro J; Andersen JF
    J Biol Chem; 2021; 296():100083. PubMed ID: 33199367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and structural insight into properdin control of complement alternative pathway amplification.
    Pedersen DV; Roumenina L; Jensen RK; Gadeberg TA; Marinozzi C; Picard C; Rybkine T; Thiel S; Sørensen UB; Stover C; Fremeaux-Bacchi V; Andersen GR
    EMBO J; 2017 Apr; 36(8):1084-1099. PubMed ID: 28264884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly.
    Spitzer D; Mitchell LM; Atkinson JP; Hourcade DE
    J Immunol; 2007 Aug; 179(4):2600-8. PubMed ID: 17675523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
    van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
    Front Immunol; 2019; 10():2097. PubMed ID: 31552043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for therapeutic inhibition of complement C5.
    Jore MM; Johnson S; Sheppard D; Barber NM; Li YI; Nunn MA; Elmlund H; Lea SM
    Nat Struct Mol Biol; 2016 May; 23(5):378-86. PubMed ID: 27018802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of C1s, C1r and properdin in the initiation of the C3b-dependent feedback mechanism of the complement system.
    Johnson U
    Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):73-8. PubMed ID: 696332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.
    Michels MAHM; van de Kar NCAJ; van den Bos RM; van der Velden TJAM; van Kraaij SAW; Sarlea SA; Gracchi V; Oosterveld MJS; Volokhina EB; van den Heuvel LPWJ
    Front Immunol; 2019; 10():1350. PubMed ID: 31263464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
    Chen JY; Galwankar NS; Emch HN; Menon SS; Cortes C; Thurman JM; Merrill SA; Brodsky RA; Ferreira VP
    Front Immunol; 2020; 11():1460. PubMed ID: 32793201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant two-module form of human properdin is an inhibitor of the complement alternative pathway.
    Kouser L; Abdul-Aziz M; Tsolaki AG; Singhal D; Schwaeble WJ; Urban BC; Khan HA; Sim RB; Kishore U
    Mol Immunol; 2016 May; 73():76-87. PubMed ID: 27060503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Properdin in C5 Convertase Activity and C5b-9 Formation in the Complement Alternative Pathway.
    Michels MAHM; Maas RJF; van der Velden TJAM; van de Kar NCAJ; van den Heuvel LPWJ; Volokhina EB;
    J Immunol; 2021 Nov; 207(10):2465-2472. PubMed ID: 34635587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.
    Alcorlo M; Tortajada A; Rodríguez de Córdoba S; Llorca O
    Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13504-9. PubMed ID: 23901101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel complement C3 like gene (Lv-C3L) from Litopenaeus vannamei with bacteriolytic and hemolytic activities and its role in antiviral immune response.
    Liu Y; Song Q; Li D; Zou R; Zhang Y; Hao S; Geng X; Sun J
    Fish Shellfish Immunol; 2019 Aug; 91():376-387. PubMed ID: 31125666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.